Viking Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
Go back to Viking Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 39.54 +1.50 (3.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.04 | 52 Week High | $5.17 | |||
| Open | $38.04 | 52 Week Low | $0.94 | |||
| Day High | $39.64 | P/E | N/A | |||
| Day Low | $37.41 | EPS | $0.00 | |||
| Volume | 2,887,616 | |||||
